
|Videos|February 6, 2021
Aerie COO: Expanding innovation of glaucoma therapeutics
Author(s)OT Staff Reports
Tom Mitro, president, COO of Aerie Pharmaceuticals, discusses the key highlights from an industry panel discussion titled "Innovate without borders," held during the Glaucoma 360 New Horizons Forum, including the company's role in expanding into the global glaucoma therapeutics market.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
3
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
4
New optoretinography technique allows direct measurement of rod function in vivo
5












































